# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001819790-24-000004
Filing Date
2024-01-08
Accepted
2024-01-08 09:00:13
Documents
36
Period of Report
2024-01-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | tars-20240108.htm iXBRL | 8-K | 27777
2 | JPM CORPORATE PRESENTATION | a2024tarsuscorporatepres.htm | EX-99.1 | 24919
6 |  | a2024tarsuscorporatepres001.jpg | GRAPHIC | 67418
7 |  | a2024tarsuscorporatepres002.jpg | GRAPHIC | 222056
8 |  | a2024tarsuscorporatepres003.jpg | GRAPHIC | 133555
9 |  | a2024tarsuscorporatepres004.jpg | GRAPHIC | 144241
10 |  | a2024tarsuscorporatepres005.jpg | GRAPHIC | 116323
11 |  | a2024tarsuscorporatepres006.jpg | GRAPHIC | 154483
12 |  | a2024tarsuscorporatepres007.jpg | GRAPHIC | 78295
13 |  | a2024tarsuscorporatepres008.jpg | GRAPHIC | 111740
14 |  | a2024tarsuscorporatepres009.jpg | GRAPHIC | 93118
15 |  | a2024tarsuscorporatepres010.jpg | GRAPHIC | 117270
16 |  | a2024tarsuscorporatepres011.jpg | GRAPHIC | 152559
17 |  | a2024tarsuscorporatepres012.jpg | GRAPHIC | 109964
18 |  | a2024tarsuscorporatepres013.jpg | GRAPHIC | 102494
19 |  | a2024tarsuscorporatepres014.jpg | GRAPHIC | 95613
20 |  | a2024tarsuscorporatepres015.jpg | GRAPHIC | 46888
21 |  | a2024tarsuscorporatepres016.jpg | GRAPHIC | 121520
22 |  | a2024tarsuscorporatepres017.jpg | GRAPHIC | 126530
23 |  | a2024tarsuscorporatepres018.jpg | GRAPHIC | 107921
24 |  | a2024tarsuscorporatepres019.jpg | GRAPHIC | 93242
25 |  | a2024tarsuscorporatepres020.jpg | GRAPHIC | 108578
26 |  | a2024tarsuscorporatepres021.jpg | GRAPHIC | 94482
27 |  | a2024tarsuscorporatepres022.jpg | GRAPHIC | 118951
28 |  | a2024tarsuscorporatepres023.jpg | GRAPHIC | 144310
| Complete submission text file | 0001819790-24-000004.txt |  | 3861062

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
3 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | tars-20240108.xsd | EX-101.SCH | 1892
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | tars-20240108_lab.xml | EX-101.LAB | 24833
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | tars-20240108_pre.xml | EX-101.PRE | 13037
30 | EXTRACTED XBRL INSTANCE DOCUMENT | tars-20240108_htm.xml | XML | 2929

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Filer) CIK: 0001819790 (see all company filings)

EIN.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39614 | Film No.: 24518591
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)